What’s Next For Novavax Stock After A Large 46% Fall In A Month?

What’s Next For Novavax Stock After A Large 46% Fall In A Month?

While it has been nearly a year since Pfizer and Moderna’s Covid-19 vaccines hit the market, Novavax has yet to commercially deploy its shot, amid persistent production and quality issues.